CDK6 and breast carcinoma: Another lncRNA frequently expressed in breast cancer, YIYA, interacts with cyclin-dependent kinase 6 (CDK6) and stimulates cell proliferation by increasing the glycolytic pathway; the expression of YIYA is an indicator of poor disease-free survival [61].